Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01406-20Source: DataRank Database

In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii is a research paper published in Antimicrobial Agents and Chemotherapy (2020). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

Linked data & code

bioproject pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.87)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Debora Rubio-Aparicio,Ruslan Tsivkovski,Dongxu Sun ORCID,Maxim Totrov ORCID,Michael Dudley

Live enrichment

PubMed:32868334 PMC:PMC7577151 OpenAlex:https://openalex.org/W3082483555

HHS | Biomedical Advanced Research and Development Authority

Grant: HHSO100201600026C

NIH HHS

Grant: S10 OD026929

National Institutes of Health

Grant: 1S10OD026929-01

Illumina NovaSeq 6000 Sequencing System

FWCI

0.87

Citation Percentile

0.7%

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

greenLicense: ASM Journals Non-Commercial TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7577151

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577151

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7577151

publisherhttps://journals.asm.org/doi/pdf/10.1128/AAC.01406-20

journalhttps://doi.org/10.1128/aac.01406-20

Fields of Study

Antibiotic Resistance in BacteriaBacterial biofilms and quorum sensingAntibiotics Pharmacokinetics and EfficacyMedicineBiology0301 basic medicine03 medical and health sciences

MeSH Terms

MeropenemAnti-Bacterial Agentsbeta-LactamasesMicrobial Sensitivity TestsCarbapenemsAcinetobacter baumanniibeta-Lactamase Inhibitors

Keywords

MeropenemAcinetobacter baumanniiMicrobiologyCarbapenemAcinetobacterPotencyBeta-lactamaseImipenemBiologyAntibioticsBeta-Lactamase InhibitorsBacteriaIn vitroAntibiotic resistancePseudomonas aeruginosaEscherichia coliGeneBiochemistryGeneticsCrabMetallo-beta-lactamasesOxa CarbapenemasesQpx7728CarbapenemsMicrobial Sensitivity Testsbeta-LactamasesAnti-Bacterial Agents

Sustainable Development Goals

SDG 3: 3. Good health

In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii

FAIR Checklist

Authors (7)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)